180 related articles for article (PubMed ID: 30064446)
1. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
[TBL] [Abstract][Full Text] [Related]
2. KiSS-1 Modulation by Epigenetic Agents Improves the Cisplatin Sensitivity of Lung Cancer Cells.
Beretta GL; Alampi D; Corno C; Carenini N; Corna E; Perego P
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732265
[TBL] [Abstract][Full Text] [Related]
3. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical Cancer Cells.
Mehta H; Ambele MA; Mokgautsi N; Moela P
Cells; 2024 Apr; 13(8):. PubMed ID: 38667315
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.
Ren T; Shan J; Li M; Qing Y; Qian C; Wang G; Li Q; Lu G; Li C; Peng Y; Luo H; Zhang S; Yang Y; Cheng Y; Wang D; Zhou SF
Drug Des Devel Ther; 2015; 9():2887-910. PubMed ID: 26089640
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.
García-Cano J; Sánchez-Tena S; Sala-Gaston J; Figueras A; Viñals F; Bartrons R; Ventura F; Rosa JL
Mol Oncol; 2020 Jan; 14(1):69-86. PubMed ID: 31665549
[TBL] [Abstract][Full Text] [Related]
6. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance.
Hossian AKMN; Zahra FT; Poudel S; Abshire CF; Polk P; Garai J; Zabaleta J; Mikelis CM; Mattheolabakis G
Sci Rep; 2021 Mar; 11(1):6520. PubMed ID: 33753779
[TBL] [Abstract][Full Text] [Related]
7. A novel cancer-germline gene DAZL promotes progression and cisplatin resistance of non-small cell lung cancer by upregulating JAK2 and MCM8.
Zhou L; Le MNU; Du Y; Chen X; Jin M; Xiang H; Xia LE; Zhou J; He J; Ning Y
Gene; 2024 Jul; 916():148449. PubMed ID: 38588931
[TBL] [Abstract][Full Text] [Related]
8. A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinoma.
Yi H; Yan X; Luo Q; Yuan L; Li B; Pan W; Zhang L; Chen H; Wang J; Zhang Y; Zhai Y; Qiu MZ; Yang DJ
J Exp Clin Cancer Res; 2018 May; 37(1):97. PubMed ID: 29716622
[TBL] [Abstract][Full Text] [Related]
9. XAF1 overexpression inhibits the malignant progression and cisplatin resistance of NSCLC by activating endoplasmic reticulum stress.
Chen B; Cheng Y; Wu H; Yao J
Mol Biol Rep; 2024 Mar; 51(1):435. PubMed ID: 38520543
[TBL] [Abstract][Full Text] [Related]
10. QiDongNing induces lung cancer cell apoptosis via triggering P53/DRP1-mediated mitochondrial fission.
Ding R; Wang Y; Xu L; Sang S; Wu G; Yang W; Zhang Y; Wang C; Qi A; Xie H; Liu Y; Dai A; Jiao L
J Cell Mol Med; 2024 May; 28(9):e18353. PubMed ID: 38682742
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis.
Wang H; Li Y; Wang Y; Shang X; Yan Z; Li S; Bao W
J Gynecol Oncol; 2024 Mar; 35(2):e13. PubMed ID: 37921598
[TBL] [Abstract][Full Text] [Related]
12. Targeting lncRNA16 by GalNAc-siRNA conjugates facilitates chemotherapeutic sensibilization via the HBB/NDUFAF5/ROS pathway.
Liu Y; Wang Y; Liu B; Liu W; Ma Y; Cao Y; Yan S; Zhang P; Zhou L; Zhan Q; Wu N
Sci China Life Sci; 2024 Apr; 67(4):663-679. PubMed ID: 38155279
[TBL] [Abstract][Full Text] [Related]
13. Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer.
Sakai H; Kawakami H; Teramura T; Onodera Y; Somers E; Furuuchi K; Uenaka T; Kato R; Nakagawa K
Clin Transl Med; 2021 Jun; 11(6):e454. PubMed ID: 34185411
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer.
Bi YY; Chen Q; Yang MY; Xing L; Jiang HL
Nat Commun; 2024 Mar; 15(1):2759. PubMed ID: 38553451
[TBL] [Abstract][Full Text] [Related]
15. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.
Zhou L; Tian Y; Guo F; Yu B; Li J; Xu H; Su Z
Cancer Immunol Immunother; 2020 May; 69(5):835-846. PubMed ID: 32062693
[TBL] [Abstract][Full Text] [Related]
16. Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and Prostate Cancer Cells In-Vitro.
Gupta A; Behl T; Heer HR; Deshmukh R; Sharma PL
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3341-3351. PubMed ID: 31759358
[TBL] [Abstract][Full Text] [Related]
17. Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment.
To KKW; Cheung KM; Cho WCS
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7217-7234. PubMed ID: 36905422
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of microarray data to determine gene indicators involved in cisplatin resistance in non-small cell lung cancer.
Sheikhshabani SH; Modarres P; Ghafouri-Fard S; Amini-Farsani Z; Khodaee L; Shaygan N; Amini-Farsani Z; Omrani MD
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1970. PubMed ID: 38351531
[TBL] [Abstract][Full Text] [Related]
19. The cancer-associated K351N mutation affects the ubiquitination and the translocation to mitochondria of p53 protein.
Muscolini M; Montagni E; Palermo V; Di Agostino S; Gu W; Abdelmoula-Souissi S; Mazzoni C; Blandino G; Tuosto L
J Biol Chem; 2011 Nov; 286(46):39693-702. PubMed ID: 21953469
[TBL] [Abstract][Full Text] [Related]
20. TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferation.
Niture S; Gyamfi MA; Lin M; Chimeh U; Dong X; Zheng W; Moore J; Kumar D
Cell Death Dis; 2020 Mar; 11(3):178. PubMed ID: 32152268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
